SCHEMBL28917138

SCHEMBL28917138

COc1cc2c(Cc3cc[c]cc3)nn(C)c(=O)c2cc1OC

nearest known ligand 0.63

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 5/20 0.63
▸ LMNA P02545 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HRH1 P35367 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24000834 0.84 ENPP1 (0.69) ENPP1HRH1
Hydrochloric Acid SCHEMBL30088839 0.83 ENPP1 (0.68) ENPP1HRH1
SCHEMBL24000850 0.83 ENPP1 (0.75) ENPP1LMNASMN1; SMN2HTTGAA
Hydrochloric Acid SCHEMBL30088949 0.82 ENPP1 (0.73) ENPP1LMNASMN1; SMN2HTTGAA
SCHEMBL24000639 0.79 ENPP1 (0.59) ENPP1LMNASMN1; SMN2HTTGAA
SCHEMBL28917095 0.78 ENPP1 (0.62) ENPP1LMNASMN1; SMN2HTTGAA
Hydrochloric Acid SCHEMBL31384257 0.78 ENPP1 (0.68) ENPP1
Hydrochloric Acid SCHEMBL28917094 0.78 ENPP1 (0.68) ENPP1LMNASMN1; SMN2HTTGAA
Hydrochloric Acid SCHEMBL31384211 0.78 ENPP1 (0.59) ENPP1LMNASMN1; SMN2HTTGAA
Hydrochloric Acid SCHEMBL30088972 0.78 ENPP1 (0.68) ENPP1LMNASMN1; SMN2HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515939-A Novel phthalazine derivatives having an inhibitory activity on ectonucleotide pyrophosphatase-phosphodiesterase and their use 谛希诺生物科技有限公司 2022-12-23 — — CN claimed
CN-115515939-A Novel phthalazine derivatives having an inhibitory activity on ectonucleotide pyrophosphatase-phosphodiesterase and their use 谛希诺生物科技有限公司 2022-12-23 — — CN disclosed
Send feedback